Harvest Fund Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.16M | Sell |
6,027
-773
| -11% | -$405K | 0.15% | 108 |
|
|
2025
Q1 | $4.31M | Buy |
6,800
+440
| +7% | +$279K | 0.21% | 84 |
|
|
2024
Q4 | $4.39M | Buy |
6,360
+1,366
| +27% | +$942K | 0.2% | 85 |
|
|
2024
Q3 | $5.25M | Buy |
4,994
+1,523
| +44% | +$1.6M | 0.31% | 59 |
|
|
2024
Q2 | $3.65M | Sell |
3,471
-170
| -5% | -$179K | 0.26% | 62 |
|
|
2024
Q1 | $3.5M | Buy |
3,641
+2,449
| +205% | +$2.36M | 0.31% | 61 |
|
|
2023
Q4 | $1.03M | Buy |
1,192
+101
| +9% | +$87.5K | 0.16% | 77 |
|
|
2023
Q3 | $898K | Buy |
1,091
+479
| +78% | +$394K | 0.16% | 78 |
|
|
2023
Q2 | $440K | Sell |
612
-26
| -4% | -$18.7K | 0.09% | 119 |
|
|
2023
Q1 | $524K | Buy |
638
+53
| +9% | +$43.5K | 0.12% | 95 |
|
|
2022
Q4 | $420K | Buy |
585
+145
| +33% | +$104K | 0.11% | 118 |
|
|
2022
Q3 | $303K | Sell |
440
-81
| -16% | -$55.8K | 0.09% | 128 |
|
|
2022
Q2 | $308K | Hold |
521
| – | – | 0.09% | 114 |
|
|
2022
Q1 | $363K | Sell |
521
-39
| -7% | -$27.2K | 0.08% | 123 |
|
|
2021
Q4 | $360K | Buy |
560
+153
| +38% | +$98.4K | 0.06% | 146 |
|
|
2021
Q3 | $246K | Buy |
407
+306
| +303% | +$185K | 0.06% | 120 |
|
|
2021
Q2 | $58K | Sell |
101
-35
| -26% | -$20.1K | 0.01% | 387 |
|
|
2021
Q1 | $64K | Sell |
136
-178
| -57% | -$83.8K | 0.01% | 348 |
|
|
2020
Q4 | $151K | Sell |
314
-736
| -70% | -$354K | 0.01% | 187 |
|
|
2020
Q3 | $635K | Buy |
1,050
+528
| +101% | +$319K | 0.05% | 69 |
|
|
2020
Q2 | $317K | Buy |
522
+72
| +16% | +$43.7K | 0.03% | 98 |
|
|
2020
Q1 | $219K | Buy |
+450
| New | +$219K | 0.03% | 115 |
|
|
2019
Q2 | – | Sell |
-425
| Closed | -$175K | – | 418 |
|
|
2019
Q1 | $175K | Buy |
425
+191
| +82% | +$78.6K | 0.03% | 127 |
|
|
2018
Q4 | $87K | Buy |
+234
| New | +$87K | 0.02% | 194 |
|
|
2017
Q4 | – | Sell |
-58
| Closed | -$26K | – | 245 |
|
|
2017
Q3 | $26K | Hold |
58
| – | – | ﹤0.01% | 185 |
|
|
2017
Q2 | $28K | Buy |
+58
| New | +$28K | ﹤0.01% | 193 |
|